Development and validation of a 13-item short version of the inflammatory bowel disease self-efficacy scale.

ABSTRACT:

Background

The inflammatory bowel disease self-efficacy scale (IBD-SES) is an instrument used across many countries to measure important health outcomes of patients with inflammatory bowel disease (IBD). We aimed to develop and validate a substantially shorter version of this scale to reduce patients' response burden.

Methods

A total of 919 patients with IBD, 482 recruited from an IBD clinic and 437 recruited online, completed the Japanese version of the original, 29-item IBD-SES. These data were then used to develop a shorter version of the scale. The original 29 items of the IBD-SES were reduced with three analytic steps: assessing ceiling and floor effect, testing correlation between items, and assessing test-retest reliability. The resulting 13-item IBD-SES was evaluated

SUBMITTER: Tanaka M 

PROVIDER: S-EPMC11141053 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature